Braf v600e mutation-positive unresectable advanced or recurrent solid tumor Clinical Trials

Delta Trials catalogs 1 clinical trial for Braf v600e mutation-positive unresectable advanced or recurrent solid tumor in its publicly accessible dataset. Within this set, 1 currently recruiting participants and 0 trials have reached completion. This research occurs across 48 participating sites around the world. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.